UK markets open in 5 hours 52 minutes
NIKKEI 225
38,107.83 -297.83 (-0.78%) HANG SENG
17,763.03 +16.12 (+0.09%) CRUDE OIL
81.12 -0.81 (-0.99%) GOLD FUTURES
2,297.30 -5.60 (-0.24%) DOW
37,815.92 -570.17 (-1.49%) Bitcoin GBP
48,203.12 -3,394.00 (-6.58%)
ADC Therapeutics SA (ADCT)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 372.66M |
| Enterprise value | 218.44M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 5.29 |
| Price/book (mrq) | N/A |
| Enterprise value/revenue | 3.14 |
| Enterprise value/EBITDA | -1.50 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.74 |
| 52-week change 3 | 136.84% |
| S&P500 52-week change 3 | 24.19% |
| 52-week high 3 | 6.0400 |
| 52-week low 3 | 0.3600 |
| 50-day moving average 3 | 4.6202 |
| 200-day moving average 3 | 2.2425 |
Share statistics
| Avg vol (3-month) 3 | 668.21k |
| Avg vol (10-day) 3 | 382.43k |
| Shares outstanding 5 | 82.81M |
| Implied shares outstanding 6 | 82.53M |
| Float 8 | 63.01M |
| % held by insiders 1 | 23.99% |
| % held by institutions 1 | 41.05% |
| Shares short (15 Apr 2024) 4 | 888.13k |
| Short ratio (15 Apr 2024) 4 | 1.81 |
| Short % of float (15 Apr 2024) 4 | 1.65% |
| Short % of shares outstanding (15 Apr 2024) 4 | 1.08% |
| Shares short (prior month 15 Mar 2024) 4 | 939.75k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -221.69% |
Management effectiveness
| Return on assets (ttm) | -24.54% |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | 69.56M |
| Revenue per share (ttm) | 0.85 |
| Quarterly revenue growth (yoy) | -75.90% |
| Gross profit (ttm) | N/A |
| EBITDA | -164.8M |
| Net income avi to common (ttm) | -240.05M |
| Diluted EPS (ttm) | -2.9400 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 278.6M |
| Total cash per share (mrq) | 3.38 |
| Total debt (mrq) | 427.95M |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 4.97 |
| Book value per share (mrq) | -1.80 |
Cash flow statement
| Operating cash flow (ttm) | -118.69M |
| Levered free cash flow (ttm) | -79.93M |
© 2024 Yahoo. All rights reserved.